Literature DB >> 16426926

A case of retroperitoneal and mediastinal fibrosis exhibiting elevated levels of IgG4 in the absence of sclerosing pancreatitis (autoimmune pancreatitis).

Yoh Zen1, Aiko Sawazaki, Shiro Miyayama, Kazuo Notsumata, Nobuyoshi Tanaka, Yasuni Nakanuma.   

Abstract

There is now increasing evidence that IgG4 is closely involved in idiopathic sclerosing lesions, such as sclerosing pancreatitis and sclerosing sialadenitis. In this report, we describe a case of IgG4-related retroperitoneal and mediastinal fibroses. A 52-year-old man presented with dull back pain and was found to have a continuously surrounding paraaortic mass. A biopsy specimen taken from the retroperitoneum showed a diffuse lymphoplasmacytic infiltration intermixed with fibrosis. Many IgG4-positive plasma cells were demonstrated on immunostaining. His serum IgG4 concentration was 392 mg/dL (reference range, <70). We treated this patient with a corticosteroid, which markedly diminished the paraaortic mass along with lowering of his serum IgG4 concentration. The possible involvement of IgG4 was suggested in the pathogeneses of retroperitoneal and mediastinal fibroses in this patient. IgG4 might be useful in the clinical management of retroperitoneal or mediastinal fibrosis to differentiate them from malignant tumors and predict steroid sensitivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16426926     DOI: 10.1016/j.humpath.2005.11.001

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  24 in total

1.  A case of extraocular muscle swelling due to IgG4-related sclerosing disease.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Satoshi Ugi; Mitsuaki Ishida; Yoshihiko Nishio; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2011-05-13       Impact factor: 2.447

2.  IgG4-related Inflammatory Abdominal Aortic Aneurysm, Spectrum of IgG4-related Chronic Periaortitis.

Authors:  Satomi Kasashima; Yoh Zen
Journal:  Ann Vasc Dis       Date:  2010-12-02

3.  IgG4-related mastitis, a rare disease, can radiologically and histologically mimic malignancy.

Authors:  Rin Yamada; Shin-ichiro Horiguchi; Toshinari Yamashita; Terumi Kamisawa
Journal:  BMJ Case Rep       Date:  2016-03-23

4.  Syndrome of pleural and retrosternal "bridging" fibrosis and retroperitoneal fibrosis in patients with asbestos exposure.

Authors:  Vincent Cottin; Pierre-Yves Brillet; François Combarnous; Florence Duperron; Hilario Nunes; Jean-François Cordier
Journal:  BMJ Case Rep       Date:  2009-02-02

Review 5.  Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.

Authors:  Giovanni M Rossi; Giacomo Emmi; Domenico Corradi; Maria L Urban; Federica Maritati; Federica Landini; Paola Galli; Alessandra Palmisano; Augusto Vaglio
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

6.  Retroperitoneal fibrosis and constrictive pericarditis-IgG4 related diseases: A case report.

Authors:  Brankica Terzic; Marijan Spasic; Predrag Djuric; Vladimir Vasiljevic; Slavica Radjen; Mirjana Mijuskovic
Journal:  Exp Ther Med       Date:  2017-05-04       Impact factor: 2.447

Review 7.  Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  J Gastroenterol       Date:  2006-07       Impact factor: 7.527

Review 8.  [Motility disorders of the esophagus].

Authors:  E Bruder; A-L Rougemont; R I Furlano; J F Schneider; J Mayr; F-M Haecker; K Beier; J Schneider; P Weber; T Berberich; G Cathomas; W A Meier-Ruge
Journal:  Pathologe       Date:  2013-03       Impact factor: 1.011

Review 9.  IgG4-related sclerosing disease.

Authors:  Terumi Kamisawa; Atsutake Okamoto
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 10.  IgG4-related sclerosing cholangitis: all we need to know.

Authors:  Yoh Zen; Hiroshi Kawakami; Jung Hoon Kim
Journal:  J Gastroenterol       Date:  2016-01-27       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.